Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001–2010: a retrospective, population based analysis

Fig. 1

Overall survival in patients ≤ 60 years of age receiving ASCT. Blue curve: Patients who started treatment in the period 01.01.2001–31.06.2005 (n = 99). Median overall survival: 70.6 months (95% CI 53.2–88.1). Green curve: Patients who started treatment in the period 01.07.2005–31.12.2009 (n = 113). Median overall survival: 87.7 months (95% CI 75.2–100.1). P = 0.21 (ns)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us